Gergely Bence

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2023-2026

2026

Gergely, B., Vereb, M. A., Rebenku, I., Szöőr, Á., Vereb, G.: Breaking the barrier: Synergistic 2B4.4-1BB signaling potentiates HER2-CAR NK cells to penetrate and destroy ADCC-resistant tumors.
Cancer Lett. 651, 1-9, (article identifier: 218534), 2026.

doi DEA

Journal metrics:

Q1 Cancer Research (2025)

D1 Oncology (2025)

2025

Gergely, B., Vereb, M. A., Rebenku, I., Vereb, G., Szöőr, Á.: Targeting HER2-Positive Solid Tumors with CAR NK Cells: CD44 Expression Is a Critical Modulator of HER2-Specific CAR NK Cell Efficacy.
Cancers. 17 (5), 1-17, (article identifier: 731), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

2024

Barden, M., Elsenbroich, P. R., Haas, V., Ertelt, M., Pervan, P., Velas, L., Gergely, B., Szöőr, Á., Harrer, D. C., Bezler, V., Holzinger, A., Friis, R. U. W., Vereb, G., Schütz, G., Schoeder, C. T., Hombach, A. A., Abken, H.: Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.
J. Immunother. Cancer. 12 (12), 1-14, (article identifier: 010208), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Cancer Research

D1 Immunology

D1 Immunology and Allergy

D1 Molecular Medicine

D1 Oncology

D1 Pharmacology

2023

Kola, J. B., Turarova, B., Csige, D., Sipos, Á., Varga, L., Gergely, B., Refai, F. A., Uray, I. P., Docsa, T., Uray, K.: Stretch-Induced Down-Regulation of HCN2 Suppresses Contractile Activity.
Molecules. 28 (11), 1-14, (article identifier: 4359), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Analytical Chemistry

Q1 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry